Travere Therapeutics (TVTX) PT Lowered to $35 at Evercore ISI
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $62.14 +1.16%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Evercore ISI analyst Gavin Clark-Gartner lowered the price target on Travere Therapeutics (NASDAQ: TVTX) to $35.00 (from $45.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
